Pinned post
Radical Cystectomy shouldn't be the only conversation after EV-Pembro.
Scott E Delacroix Jr M.D.
Verified account This account is verified. Learn more@UroCancer
Medical Director Urologic Oncology/GU Cancers. Mary Bird Perkins Cancer Center. Metairie, Louisiana. Bladder and Prostate Cancer subspecialty.
1.1K Following 1.9K Followers 2.5K Posts
Latest posts 5
Fodder for an adaptive trial on both sides of the equation (escalate/de-escalate). Add cfRNA @max_diehn for response characterization at baseline? Excited about future trials and an informed adaptive landscape in HRNMIBC beyond initial risk stratification and blunt Rx. Lots of opportunities to potentially advance our treatments. swog 1602 publication should benchmark outcomes for design.
sciencedirect.com/science/articl…
Data from INSITE Yair Lotan at al. effect modification of utDNA on mBCG for #bladdercancer. Argument for BCG being therapeutic and not preventative. Very informativeView quoted post on X
Recommended reading materials prior to second opinions…. @dr_coops @uroegg @VickersBiostats @OtisBrawley (and of course the PCF new diagnosis pdf).
Pragmatic and timely design. Glad we have it in the portfolio.
.@MonikaJoshimd and @PGrivasMDPhD are leading #ClinicalTrial EA8231, a phase 3 randomized trial comparing the effectiveness of pembrolizumab and sacituzumab govitecan to standard-of-care chemo in patients with advanced #UrothelialCancer. bit.ly/ea8231-studyView quoted post on X
Love this.
I love Cajuns, man. Them is our little slice of French that Canada gave us. Salt of God's green Earth people.View quoted post on X
